S. Dittmer

Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years

Sharon Nachman, Naiyu Zheng, Edward P. Acosta et al. · Clinical Infectious Diseases · 2013 · 59 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany

R. Seufert, Ludwig Sedlacek, Barbara C. Kahl et al. · Journal of Antimicrobial Chemotherapy · 2018 · 52 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: Molecular diversity, mutation frequency and antibiotic resistance

Pedrina Gonçalves Vidigal, S. Dittmer, Eike Steinmann et al. · International Journal of Medical Microbiology · 2014 · 39 citations · Full text

Life Sciences, Genetics, Microbiology +17

<i>In vitro</i> activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis

Haemi P. Schemuth, S. Dittmer, Michaela Lackner et al. · Mycoses · 2012 · 29 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

<i>In Vitro</i> Activity of Isavuconazole against Rasamsonia Species

Joerg Steinmann, S. Dittmer, Jos Houbraken et al. · Antimicrobial Agents and Chemotherapy · 2016 · 26 citations · Full text

Life Sciences, Microbiology, Pharmacology +12